News Daily News FDA: Medtronic Stops Production and Distribution of Troubled HeartWare VAD L.A. McKeown June 03, 2021
News Daily News TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State Michael O'Riordan January 22, 2020
News Daily News FDA Approves HeartMate 3 as Destination Therapy in Advanced HF Michael O'Riordan October 19, 2018
News Daily News FDA Grants HeartWare LVAD a Destination Therapy Indication Todd Neale September 28, 2017
News Industry News HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial August 10, 2015
News Industry News Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy June 16, 2015